National Day Pharmaceutical Joint Stock Co
UUPCOM:NDP22,000.00
VND
0.00
(0.00%)
ISIN
VN000000NDP9
Return %
Stock
S&P 500
1Y
0.00
14.20
3Y
-3.51
81.12
5Y
-6.38
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Ho Chi Minh City Vietnam
- IPO Date
- Nov 20, 2015
- Website
- nadyphar.com.vn
- Similar Companies
- Business
- National Day Pharmaceutical Joint Stock Company, operating under the brand name Nadyphar, is a Vietnam-based healthcare and pharmaceutical manufacturing enterprise engaged in the research, formulation, production, wholesale trading, import, export, and distribution of modern pharmaceuticals, traditional herbal medicines, cosmeceuticals, and dietary supplements. The company operates across ethical prescription (ETC) and over-the-counter (OTC) healthcare segments, offering a comprehensive product portfolio that includes analgesic and antipyretic formulations, such as the Acemol product line including Acemol 500, Acemol Fort, and Acemol Enfant; gastrointestinal and digestive health preparations, including Carbogast, Alumina, Smechedral, and Berberal; musculoskeletal treatments, such as Tizanad muscle relaxants; metabolic and endocrine medications, including Nady-Dapag for type 2 diabetes management; respiratory therapies, such as Sabumol; anti-infective, antiviral, and antiparasitic drugs, such as Acyclovir, Albendazol, and Allopurinol; cardiovascular and diuretic medications, such as Betasiphon; traditional phytomedicines and botanical extracts, such as Diep Ha Chau and Cao Con Meo; and therapeutic skincare and personal care cosmeceuticals. In addition to medicinal production, the company provides pharmaceutical warehousing, distribution logistics, and contract manufacturing services. National Day Pharmaceutical distributes its products throughout Vietnam to public and private hospitals, clinics, medical centers, commercial wholesalers, and modern retail pharmacy chains, while also engaging in selective export distribution across regional markets. Founded in 1976 as the state-owned 2/9 Pharmaceutical Enterprise and equitized as a joint stock company in 2001, the company is headquartered in District 11, Ho Chi Minh City, Vietnam, and operates primary manufacturing facilities certified under WHO-GMP, GLP, and GSP standards in the Cat Lai Industrial Park in Ho Chi Minh City. In recent developments, the company has undertaken strategic shifts to expand its presence across the institutional hospital channel while deepening distribution agreements with major national retail pharmacy chains, elected a new Board of Directors for the 2026-2030 tenure, and modernized its manufacturing lines and quality management systems to support production expansions into specialized generic therapeutics.